These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36142190)

  • 1. Immuno-PET and Targeted α-Therapy Using Anti-Glypican-1 Antibody Labeled with
    Watabe T; Kabayama K; Naka S; Yamamoto R; Kaneda K; Serada S; Ooe K; Toyoshima A; Wang Y; Haba H; Kurimoto K; Kobayashi T; Shimosegawa E; Tomiyama N; Fukase K; Naka T
    J Nucl Med; 2023 Dec; 64(12):1949-1955. PubMed ID: 37827841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of novel anti-CEACAM6 antibody-based conjugates for radioimmunotheranostics of pancreatic ductal adenocarcinoma.
    Kong Y; Xie F; Zhang Z; Wang S; Zhang Y; Di Y; Zhou Z; Jiang D; Li J; Huang Q; Wang J; Li X; Pan Z; Ni R; Guan Y
    Eur Radiol; 2023 Oct; 33(10):7077-7088. PubMed ID: 37166496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular Vesicular Analysis of Glypican 1 mRNA and Protein for Pancreatic Cancer Diagnosis and Prognosis.
    Li H; Chiang CL; Kwak KJ; Wang X; Doddi S; Ramanathan LV; Cho SM; Hou YC; Cheng TS; Mo X; Chang YS; Chang HL; Cheng W; Tsai WN; Nguyen LTH; Pan J; Ma Y; Rima XY; Zhang J; Reategui E; Chu YS; Chang PM; Chang PH; Huang CF; Wang CH; Shan YS; Li CP; Fleisher M; Lee LJ
    Adv Sci (Weinh); 2024 Mar; 11(11):e2306373. PubMed ID: 38204202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic Therapy for Patients With Pancreatic Cancer: Current Approaches and Opportunities for Novel Avenues Toward Precision Medicine.
    Ayasun R; Saridogan T; Gaber O; Sahin IH
    Clin Colorectal Cancer; 2023 Mar; 22(1):2-11. PubMed ID: 36418197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theranostic nanoparticles for detection and treatment of pancreatic cancer.
    Agarwal H; Bynum RC; Saleh N; Harris D; MacCuaig WM; Kim V; Sanderson EJ; Dennahy IS; Singh R; Behkam B; Gomez-Gutierrez JG; Jain A; Edil BH; McNally LR
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(4):e1983. PubMed ID: 39140128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic developments in pancreatic cancer.
    Hu ZI; O'Reilly EM
    Nat Rev Gastroenterol Hepatol; 2024 Jan; 21(1):7-24. PubMed ID: 37798442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Nanoparticle-Based Diagnostic and Treatment Options for Pancreatic Cancer.
    Gu X; Minko T
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Preclinical Targeting of Oncogenic Pathways in PDAC: Targeted Therapeutic Approaches for the Deadliest Cancer.
    Jiménez DJ; Javed A; Rubio-Tomás T; Seye-Loum N; Barceló C
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging applications of cancer bacteriotherapy towards treatment of pancreatic cancer.
    Henderson EA; Lukomski S; Boone BA
    Front Oncol; 2023; 13():1217095. PubMed ID: 37588093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated proteomic profiling identifies amino acids selectively cytotoxic to pancreatic cancer cells.
    Akinlalu A; Flaten Z; Rasuleva K; Mia MS; Bauer A; Elamurugan S; Ejjigu N; Maity S; Arshad A; Wu M; Xia W; Fan J; Guo A; Mathew S; Sun D
    Innovation (Camb); 2024 May; 5(3):100626. PubMed ID: 38699777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision Therapy of Pancreatic Cancer: From Bench to Bedside.
    Ciecielski KJ; Berninger A; Algül H
    Visc Med; 2020 Oct; 36(5):373-380. PubMed ID: 33178734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Therapies for Pancreatic Cancer.
    Amanam I; Chung V
    Cancers (Basel); 2018 Jan; 10(2):. PubMed ID: 29382159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Administration of Cancer Vaccines: Challenges and Future Perspectives.
    Gambirasi M; Safa A; Vruzhaj I; Giacomin A; Sartor F; Toffoli G
    Vaccines (Basel); 2023 Dec; 12(1):. PubMed ID: 38250839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in Immunotherapy and Innovative Therapeutic Approaches for Cancer Treatment: Editorial to the Special Issue "State-of-the-Art Molecular Oncology in Italy".
    Laudisi F; Stolfi C
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of potent and noncovalent KRAS
    Wang Y; Zhang H; Li J; Niu MM; Zhou Y; Qu Y
    Front Pharmacol; 2022; 13():1094887. PubMed ID: 36618907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Proteoglycan Glypican-1 as a Possible Candidate for Innovative Targeted Therapeutic Strategies for Pancreatic Ductal Adenocarcinoma.
    Busato D; Mossenta M; Dal Bo M; Macor P; Toffoli G
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinoma.
    Busato D; Capolla S; Durigutto P; Mossenta M; Bozzer S; Sblattero D; Macor P; Dal Bo M; Toffoli G
    J Transl Med; 2023 Nov; 21(1):864. PubMed ID: 38017492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A glypican-1-targeted antibody-drug conjugate exhibits potent tumor growth inhibition in glypican-1-positive pancreatic cancer and esophageal squamous cell carcinoma.
    Munekage E; Serada S; Tsujii S; Yokota K; Kiuchi K; Tominaga K; Fujimoto M; Kanda M; Uemura S; Namikawa T; Nomura T; Murakami I; Hanazaki K; Naka T
    Neoplasia; 2021 Sep; 23(9):939-950. PubMed ID: 34332450
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.